Rank | Gene Set | Z-score |
---|---|---|
1 | drug transmembrane transport (GO:0006855) | 9.66791052 |
2 | aminoglycoside antibiotic metabolic process (GO:0030647) | 9.38077328 |
3 | cardiovascular system development (GO:0072358) | 9.25320680 |
4 | lysine metabolic process (GO:0006553) | 9.08426875 |
5 | lysine catabolic process (GO:0006554) | 9.08426875 |
6 | drug transport (GO:0015893) | 8.27783900 |
7 | organic cation transport (GO:0015695) | 8.17437208 |
8 | phosphate ion transport (GO:0006817) | 7.94465906 |
9 | response to water (GO:0009415) | 7.87903853 |
10 | response to mercury ion (GO:0046689) | 7.36580230 |
11 | positive regulation of catenin import into nucleus (GO:0035413) | 7.15249028 |
12 | response to lead ion (GO:0010288) | 7.11830597 |
13 | renal absorption (GO:0070293) | 6.92708330 |
14 | activation of transmembrane receptor protein tyrosine kinase activity (GO:0007171) | 6.87255604 |
15 | positive regulation of epidermal growth factor-activated receptor activity (GO:0045741) | 6.87179522 |
16 | * excretion (GO:0007588) | 6.85990552 |
17 | positive regulation of protein ubiquitination involved in ubiquitin-dependent protein catabolic proc | 6.85541365 |
18 | phosphate ion transmembrane transport (GO:0035435) | 6.75429907 |
19 | quaternary ammonium group transport (GO:0015697) | 6.52121579 |
20 | cysteine metabolic process (GO:0006534) | 6.42695521 |
21 | negative regulation of sterol transport (GO:0032372) | 6.28315114 |
22 | negative regulation of cholesterol transport (GO:0032375) | 6.28315114 |
23 | glyoxylate metabolic process (GO:0046487) | 6.24134091 |
24 | mesenchymal to epithelial transition involved in metanephros morphogenesis (GO:0003337) | 6.22413653 |
25 | response to thyroid hormone (GO:0097066) | 6.17319798 |
26 | * metanephric epithelium development (GO:0072207) | 6.11762044 |
27 | aspartate family amino acid catabolic process (GO:0009068) | 6.04134381 |
28 | regulation of metanephric nephron tubule epithelial cell differentiation (GO:0072307) | 6.01378711 |
29 | negative regulation of metanephros development (GO:0072217) | 5.94870641 |
30 | nephron tubule formation (GO:0072079) | 5.88057587 |
31 | tricarboxylic acid metabolic process (GO:0072350) | 5.87736621 |
32 | regulation of apoptotic process involved in morphogenesis (GO:1902337) | 5.72208471 |
33 | response to magnesium ion (GO:0032026) | 5.68938992 |
34 | vitamin D metabolic process (GO:0042359) | 5.58957870 |
35 | short-chain fatty acid metabolic process (GO:0046459) | 5.48868668 |
36 | regulation of mesenchymal to epithelial transition involved in metanephros morphogenesis (GO:0003339 | 5.47165592 |
37 | hyperosmotic response (GO:0006972) | 5.45513778 |
38 | nonribosomal peptide biosynthetic process (GO:0019184) | 5.45216899 |
39 | drug catabolic process (GO:0042737) | 5.42511051 |
40 | sodium-independent organic anion transport (GO:0043252) | 5.41646307 |
41 | polyol transport (GO:0015791) | 5.39100507 |
42 | response to copper ion (GO:0046688) | 5.33925130 |
43 | inositol metabolic process (GO:0006020) | 5.28377779 |
44 | valine metabolic process (GO:0006573) | 5.25270761 |
45 | branched-chain amino acid metabolic process (GO:0009081) | 5.21155575 |
46 | 2-oxoglutarate metabolic process (GO:0006103) | 5.20636337 |
47 | homocysteine metabolic process (GO:0050667) | 5.20588727 |
48 | toxin transport (GO:1901998) | 5.17568906 |
49 | tryptophan catabolic process (GO:0006569) | 5.01739519 |
50 | indole-containing compound catabolic process (GO:0042436) | 5.01739519 |
51 | indolalkylamine catabolic process (GO:0046218) | 5.01739519 |
52 | amino-acid betaine transport (GO:0015838) | 4.95566910 |
53 | carnitine transport (GO:0015879) | 4.95566910 |
54 | response to vitamin A (GO:0033189) | 4.92989334 |
55 | exogenous drug catabolic process (GO:0042738) | 4.92068407 |
56 | glutathione biosynthetic process (GO:0006750) | 4.91687269 |
57 | cellular response to ammonium ion (GO:0071242) | 4.91490132 |
58 | aromatic amino acid family catabolic process (GO:0009074) | 4.91288400 |
59 | bone remodeling (GO:0046849) | 4.85539175 |
60 | * nephron tubule development (GO:0072080) | 4.85368117 |
61 | modified amino acid transport (GO:0072337) | 4.83232309 |
62 | negative regulation of mesenchymal cell apoptotic process (GO:2001054) | 4.81100828 |
63 | pattern specification involved in kidney development (GO:0061004) | 4.78790712 |
64 | regulation of protein localization to cell surface (GO:2000008) | 4.73941618 |
65 | tryptophan metabolic process (GO:0006568) | 4.71573042 |
66 | erythrose 4-phosphate/phosphoenolpyruvate family amino acid metabolic process (GO:1902221) | 4.65352354 |
67 | L-phenylalanine metabolic process (GO:0006558) | 4.65352354 |
68 | trivalent inorganic anion homeostasis (GO:0072506) | 4.64428686 |
69 | phosphate ion homeostasis (GO:0055062) | 4.64428686 |
70 | renal system process (GO:0003014) | 4.58735640 |
71 | erythrose 4-phosphate/phosphoenolpyruvate family amino acid catabolic process (GO:1902222) | 4.56483015 |
72 | L-phenylalanine catabolic process (GO:0006559) | 4.56483015 |
73 | mammary gland alveolus development (GO:0060749) | 4.47581875 |
74 | amino-acid betaine metabolic process (GO:0006577) | 4.45074017 |
75 | fatty acid beta-oxidation using acyl-CoA oxidase (GO:0033540) | 4.40941275 |
76 | acetyl-CoA metabolic process (GO:0006084) | 4.40636163 |
77 | branched-chain amino acid catabolic process (GO:0009083) | 4.39979099 |
78 | fatty acid beta-oxidation (GO:0006635) | 4.37789025 |
79 | positive regulation of peptidyl-threonine phosphorylation (GO:0010800) | 4.37265412 |
80 | cellular ketone body metabolic process (GO:0046950) | 4.35323864 |
81 | cellular modified amino acid catabolic process (GO:0042219) | 4.35265361 |
82 | ERK1 and ERK2 cascade (GO:0070371) | 4.32507275 |
83 | * renal tubule development (GO:0061326) | 4.31422879 |
84 | serine family amino acid catabolic process (GO:0009071) | 4.26464568 |
85 | glycoside metabolic process (GO:0016137) | 4.26358007 |
86 | kynurenine metabolic process (GO:0070189) | 4.25091372 |
87 | serine family amino acid metabolic process (GO:0009069) | 4.24646134 |
88 | fructose metabolic process (GO:0006000) | 4.23750610 |
89 | proline metabolic process (GO:0006560) | 4.21716318 |
90 | protein depolymerization (GO:0051261) | 4.20521866 |
91 | response to salt stress (GO:0009651) | 4.18522624 |
92 | glutamate metabolic process (GO:0006536) | 4.16981800 |
93 | carnitine metabolic process (GO:0009437) | 4.16805021 |
94 | regulation of fever generation (GO:0031620) | 4.08522575 |
95 | glomerular visceral epithelial cell development (GO:0072015) | 4.07469505 |
96 | fatty acid oxidation (GO:0019395) | 4.06941896 |
97 | response to phenylpropanoid (GO:0080184) | 4.05887256 |
98 | regulation of protein ubiquitination involved in ubiquitin-dependent protein catabolic process (GO:2 | 4.00854304 |
99 | lipid oxidation (GO:0034440) | 3.99260435 |
100 | positive regulation of heat generation (GO:0031652) | 3.95243316 |
101 | * nephron epithelium development (GO:0072009) | 3.94386931 |
102 | peptide biosynthetic process (GO:0043043) | 3.91184110 |
103 | regulation of potassium ion transmembrane transporter activity (GO:1901016) | 3.88736060 |
104 | NADH metabolic process (GO:0006734) | 3.85052619 |
105 | cell differentiation involved in metanephros development (GO:0072202) | 3.84434953 |
106 | urogenital system development (GO:0001655) | 3.82946441 |
107 | L-methionine biosynthetic process (GO:0071265) | 3.82004032 |
108 | amino acid salvage (GO:0043102) | 3.82004032 |
109 | L-methionine salvage (GO:0071267) | 3.82004032 |
110 | beta-amyloid metabolic process (GO:0050435) | 3.78848599 |
111 | S-adenosylmethionine metabolic process (GO:0046500) | 3.78539977 |
112 | regulation of cholesterol efflux (GO:0010874) | 3.77698334 |
113 | ketone body metabolic process (GO:1902224) | 3.74393770 |
114 | regulation of nephron tubule epithelial cell differentiation (GO:0072182) | 3.73958806 |
115 | positive regulation of epidermal growth factor receptor signaling pathway (GO:0045742) | 3.72017871 |
116 | * metanephric nephron tubule development (GO:0072234) | 3.67070895 |
117 | * metanephric tubule development (GO:0072170) | 3.67070895 |
118 | regulation of mesenchymal cell apoptotic process (GO:2001053) | 3.66131673 |
119 | peptide catabolic process (GO:0043171) | 3.65087438 |
120 | response to growth hormone (GO:0060416) | 3.64342503 |
121 | cellular amino acid catabolic process (GO:0009063) | 3.62628462 |
122 | vitamin transport (GO:0051180) | 3.60903935 |
123 | aromatic amino acid family metabolic process (GO:0009072) | 3.60527047 |
124 | fatty acid catabolic process (GO:0009062) | 3.58572398 |
125 | glomerular epithelial cell development (GO:0072310) | 3.57650600 |
126 | indole-containing compound metabolic process (GO:0042430) | 3.56356152 |
127 | mesonephros development (GO:0001823) | 3.55757129 |
128 | alpha-amino acid catabolic process (GO:1901606) | 3.54653758 |
129 | positive regulation of ERBB signaling pathway (GO:1901186) | 3.52067553 |
130 | indolalkylamine metabolic process (GO:0006586) | 3.49487352 |
131 | sodium ion transport (GO:0006814) | 3.47933389 |
132 | nephron epithelium morphogenesis (GO:0072088) | 3.45709479 |
133 | nephron tubule morphogenesis (GO:0072078) | 3.45709479 |
134 | biotin metabolic process (GO:0006768) | 3.45302113 |
135 | regulation of stem cell maintenance (GO:2000036) | 3.44669243 |
136 | tricarboxylic acid cycle (GO:0006099) | 3.44617113 |
137 | glutathione derivative biosynthetic process (GO:1901687) | 3.44529008 |
138 | glutathione derivative metabolic process (GO:1901685) | 3.44529008 |
139 | surfactant homeostasis (GO:0043129) | 3.43685552 |
140 | regulation of anion transport (GO:0044070) | 3.43576694 |
141 | regulation of catenin import into nucleus (GO:0035412) | 3.42682469 |
142 | * metanephric nephron epithelium development (GO:0072243) | 3.39183071 |
143 | succinate metabolic process (GO:0006105) | 3.38328036 |
144 | collecting duct development (GO:0072044) | 3.38244618 |
145 | cellular response to vitamin D (GO:0071305) | 3.38034360 |
146 | glutathione metabolic process (GO:0006749) | 3.37939969 |
147 | sulfur compound transport (GO:0072348) | 3.37145201 |
148 | response to lithium ion (GO:0010226) | 3.36145407 |
149 | regulation of epidermal growth factor-activated receptor activity (GO:0007176) | 3.34933701 |
150 | monocarboxylic acid catabolic process (GO:0072329) | 3.34428633 |
151 | inorganic anion transport (GO:0015698) | 3.34378506 |
152 | transepithelial transport (GO:0070633) | 3.34322341 |
153 | regulation of epithelial cell differentiation involved in kidney development (GO:2000696) | 3.33131586 |
154 | response to parathyroid hormone (GO:0071107) | 3.32342870 |
155 | organic acid catabolic process (GO:0016054) | 3.32329723 |
156 | carboxylic acid catabolic process (GO:0046395) | 3.32329723 |
157 | serine family amino acid biosynthetic process (GO:0009070) | 3.32094208 |
158 | negative regulation of kidney development (GO:0090185) | 3.31841005 |
159 | oxaloacetate metabolic process (GO:0006107) | 3.29944526 |
160 | dicarboxylic acid metabolic process (GO:0043648) | 3.28812035 |
161 | cell volume homeostasis (GO:0006884) | 3.24948774 |
162 | chloride transmembrane transport (GO:1902476) | 3.24512191 |
163 | sulfur amino acid catabolic process (GO:0000098) | 3.24071726 |
164 | oligosaccharide catabolic process (GO:0009313) | 3.23076433 |
165 | regulation of heat generation (GO:0031650) | 3.18130476 |
166 | regulation of calcium ion import (GO:0090279) | 3.17446061 |
167 | glycine metabolic process (GO:0006544) | 3.16828018 |
168 | inorganic anion transmembrane transport (GO:0098661) | 3.13586127 |
169 | mesenchymal to epithelial transition (GO:0060231) | 3.10204780 |
170 | regulation of potassium ion transmembrane transport (GO:1901379) | 3.09164252 |
171 | positive regulation of metanephros development (GO:0072216) | 3.02921952 |
172 | actin filament depolymerization (GO:0030042) | 11.4912383 |
173 | urate metabolic process (GO:0046415) | 10.0878909 |
Rank | Gene Set | Z-score |
---|---|---|
1 | ESR1_17901129_ChIP-ChIP_LIVER_Mouse | 5.88851759 |
2 | RXR_22158963_ChIP-Seq_LIVER_Mouse | 4.83788397 |
3 | PPARG_19300518_ChIP-PET_3T3-L1_Mouse | 4.34803434 |
4 | PPARA_22158963_ChIP-Seq_LIVER_Mouse | 4.00869247 |
5 | ESR1_21235772_ChIP-Seq_MCF-7_Human | 3.70659776 |
6 | LXR_22158963_ChIP-Seq_LIVER_Mouse | 3.66668191 |
7 | TAF7L_23326641_ChIP-Seq_C3H10T1-2_Mouse | 2.80054799 |
8 | ESRRB_18555785_ChIP-Seq_MESCs_Mouse | 2.65709755 |
9 | HNF4A_19761587_ChIP-ChIP_CACO-2_Human | 2.65581297 |
10 | TRP63_18441228_ChIP-ChIP_KERATINOCYTES_Mouse | 2.63144976 |
11 | RARG_19884340_ChIP-ChIP_MEFs_Mouse | 2.61502238 |
12 | CHD7_19251738_ChIP-ChIP_MESCs_Mouse | 2.60592408 |
13 | TCF21_23034159_ChIP-ChIP_E13_GONADS_Rat | 2.60059751 |
14 | CLOCK_20551151_ChIP-Seq_293T_Human | 2.49236345 |
15 | ESR2_21235772_ChIP-Seq_MCF-7_Human | 2.48332239 |
16 | TRIM28_21343339_ChIP-Seq_HEK293_Human | 2.47629258 |
17 | VDR_22108803_ChIP-Seq_LS180_Human | 2.32665088 |
18 | AR_21909140_ChIP-Seq_LNCAP_Human | 2.27032789 |
19 | NR1I2_20693526_ChIP-Seq_LIVER_Mouse | 2.10970545 |
20 | TCFCP2L1_18555785_Chip-Seq_ESCs_Mouse | 2.10602197 |
21 | KLF4_18555785_Chip-Seq_ESCs_Mouse | 2.05820510 |
22 | CDX2_20551321_ChIP-Seq_CACO-2_Human | 2.01258290 |
23 | P53_22127205_ChIP-Seq_FIBROBLAST_Human | 1.90830638 |
24 | FOXO1_23066095_ChIP-Seq_LIVER_Mouse | 1.88663845 |
25 | TCF4_18268006_ChIP-ChIP_LS174T_Human | 1.87219172 |
26 | CEBPD_23245923_ChIP-Seq_MEFs_Mouse | 1.84102434 |
27 | RUNX1_26923725_Chip-Seq_MACROPHAGESS_Mouse | 1.81729085 |
28 | ZNF217_24962896_ChIP-Seq_MCF-7_Human | 1.79344901 |
29 | TCF7L2_21901280_ChIP-Seq_H4IIE_Rat | 1.77670471 |
30 | E2F1_18555785_Chip-Seq_ESCs_Mouse | 1.76022612 |
31 | NANOG_18555785_Chip-Seq_ESCs_Mouse | 1.70883002 |
32 | NR0B1_18358816_ChIP-ChIP_MESCs_Mouse | 1.68879679 |
33 | EBF1_22473956_ChIP-Seq_BONE_MARROW_Mouse | 1.66240009 |
34 | GATA4_25053715_ChIP-Seq_YYC3_Human | 1.64202620 |
35 | OCT4_18555785_Chip-Seq_ESCs_Mouse | 1.63685606 |
36 | STAT3_18555785_Chip-Seq_ESCs_Mouse | 1.60937194 |
37 | JARID2_20064375_ChIP-Seq_MESCs_Mouse | 1.57864820 |
38 | GATA1_22025678_ChIP-Seq_K562_Human | 1.55701717 |
39 | SOX2_27498859_Chip-Seq_STOMACH_Mouse | 1.55527516 |
40 | FOXO3_23340844_ChIP-Seq_DLD1_Human | 1.54417361 |
41 | EGR1_23403033_ChIP-Seq_LIVER_Mouse | 1.51358131 |
42 | DROSHA_22980978_ChIP-Seq_HELA_Human | 1.49757516 |
43 | SMAD4_21799915_ChIP-Seq_A2780_Human | 1.49136559 |
44 | LXR_22292898_ChIP-Seq_THP-1_Human | 1.45724307 |
45 | ZFX_18555785_Chip-Seq_ESCs_Mouse | 1.45631838 |
46 | P300_18555785_Chip-Seq_ESCs_Mouse | 1.45614558 |
47 | HNF4A_19822575_ChIP-Seq_HepG2_Human | 1.45393791 |
48 | CBP_21632823_ChIP-Seq_H3396_Human | 1.45314659 |
49 | SUZ12_18555785_Chip-Seq_ESCs_Mouse | 1.44939961 |
50 | STAT5_23275557_ChIP-Seq_MAMMARY-EPITHELIUM_Mouse | 1.43652002 |
51 | P53_22387025_ChIP-Seq_ESCs_Mouse | 1.41791825 |
52 | PRDM16_22522345_ChIP-ChIP_PALATE_MESENCHYMAL_Mouse | 1.40894611 |
53 | EGR1_19032775_ChIP-ChIP_M12_Human | 1.37586956 |
54 | FOXP1_22492998_ChIP-Seq_STRATIUM_Mouse | 1.36866234 |
55 | FOXA2_19822575_ChIP-Seq_HepG2_Human | 1.36363225 |
56 | ERA_27197147_Chip-Seq_ENDOMETRIOID-ADENOCARCINOMA_Human | 1.34633353 |
57 | TCF4_22108803_ChIP-Seq_LS180_Human | 1.31084158 |
58 | RELA_24523406_ChIP-Seq_FIBROSARCOMA_Human | 1.30818721 |
59 | PCGF2_27294783_Chip-Seq_ESCs_Mouse | 1.30742636 |
60 | GLI1_17442700_ChIP-ChIP_MESCs_Mouse | 1.30088526 |
61 | SOX2_18555785_Chip-Seq_ESCs_Mouse | 1.29644567 |
62 | RACK7_27058665_Chip-Seq_MCF-7_Human | 1.29629027 |
63 | PCGF2_27294783_Chip-Seq_NPCs_Mouse | 1.29426819 |
64 | SMARCD1_25818293_ChIP-Seq_ESCs_Mouse | 1.29244816 |
65 | PU1_27457419_Chip-Seq_LIVER_Mouse | 1.29026962 |
66 | ESRRB_18555785_Chip-Seq_ESCs_Mouse | 1.28233708 |
67 | EBF1_22473956_ChIP-Seq_LYMPHODE_Mouse | 1.28161527 |
68 | RUNX1_27457419_Chip-Seq_LIVER_Mouse | 1.27326792 |
69 | CDX2_19796622_ChIP-Seq_MESCs_Mouse | 1.26381279 |
70 | CEBPB_23403033_ChIP-Seq_LIVER_Mouse | 1.26281069 |
71 | Nerf2_26677805_Chip-Seq_MACROPHAGESS_Mouse | 1.26056368 |
72 | GATA6_25053715_ChIP-Seq_YYC3_Human | 1.24554674 |
73 | SUZ12_18974828_ChIP-Seq_MESCs_Mouse | 1.24214511 |
74 | ETS2_20176728_ChIP-ChIP_TROPHOBLAST_STEM_CELLS_Mouse | 1.22385523 |
75 | PIAS1_25552417_ChIP-Seq_VCAP_Human | 1.22043789 |
76 | AR_22383394_ChIP-Seq_PROSTATE_CANCER_Human | 1.21946557 |
77 | EZH2_27294783_Chip-Seq_ESCs_Mouse | 1.21248926 |
78 | SMAD3_21741376_ChIP-Seq_HESCs_Human | 1.20982620 |
79 | TBX20_22080862_ChIP-Seq_HEART_Mouse | 1.20410823 |
80 | TBX20_22328084_ChIP-Seq_HEART_Mouse | 1.20410823 |
81 | EZH2_27304074_Chip-Seq_ESCs_Mouse | 1.19987299 |
82 | GBX2_23144817_ChIP-Seq_PC3_Human | 1.19783684 |
83 | PHF8_20622853_ChIP-Seq_HELA_Human | 1.18226150 |
84 | RXR_22108803_ChIP-Seq_LS180_Human | 1.17709182 |
85 | KDM2B_26808549_Chip-Seq_REH_Human | 1.17696219 |
86 | PPARD_23176727_ChIP-Seq_KERATINOCYTES_Mouse | 1.17218700 |
87 | NFIB_24661679_ChIP-Seq_LUNG_Mouse | 1.15040146 |
88 | CEBPB_26923725_Chip-Seq_HEMOGENIC-ENDOTHELIUM_Mouse | 1.12654936 |
89 | SMAD2/3_21741376_ChIP-Seq_EPCs_Human | 1.11963396 |
90 | TBL1_22424771_ChIP-Seq_293T_Human | 1.11861897 |
91 | SUZ12_18692474_ChIP-Seq_MEFs_Mouse | 1.11342495 |
92 | SOX2_20726797_ChIP-Seq_SW620_Human | 1.10554832 |
93 | NFYA_21822215_ChIP-Seq_K562_Human | 1.09491372 |
94 | STAT3_1855785_ChIP-Seq_MESCs_Mouse | 1.09007003 |
95 | ERG_21242973_ChIP-ChIP_JURKAT_Human | 1.08674644 |
96 | BACH1_22875853_ChIP-PCR_HELA_AND_SCP4_Human | 1.08150558 |
97 | SOX9_25088423_ChIP-ChIP_EMBRYONIC_GONADS_Mouse | 1.07657019 |
98 | FLI1_27457419_Chip-Seq_LIVER_Mouse | 1.07203800 |
99 | PPAR_26484153_Chip-Seq_NCI-H1993_Human | 1.07119715 |
100 | TAF15_26573619_Chip-Seq_HEK293_Human | 1.07078650 |
101 | SUZ12_27294783_Chip-Seq_ESCs_Mouse | 1.07075867 |
102 | TEAD4_22529382_ChIP-Seq_TROPHECTODERM_Mouse | 1.06696208 |
103 | SMARCA4_20176728_ChIP-ChIP_TSCs_Mouse | 1.06213210 |
104 | IRF1_21803131_ChIP-Seq_MONOCYTES_Human | 1.05351796 |
105 | PBX_27287812_Chip-Seq_EMBYONIC-LIMB_Mouse | 1.04668245 |
106 | SUZ12_18692474_ChIP-Seq_MESCs_Mouse | 1.04420442 |
107 | EP300_21415370_ChIP-Seq_HL-1_Mouse | 1.04146265 |
108 | SUZ12_27294783_Chip-Seq_NPCs_Mouse | 1.03880499 |
109 | SMAD1_18555785_Chip-Seq_ESCs_Mouse | 1.03614771 |
110 | AR_21915096_ChIP-Seq_LNCaP-1F5_Human | 1.02994626 |
111 | NMYC_18555785_Chip-Seq_ESCs_Mouse | 1.02923817 |
112 | ESR1_22446102_ChIP-Seq_UTERUS_Mouse | 1.02713126 |
113 | RING1B_27294783_Chip-Seq_NPCs_Mouse | 1.02335734 |
114 | FOXA1_27197147_Chip-Seq_ENDOMETRIOID-ADENOCARCINOMA_Human | 1.01998160 |
115 | GATA1_19941827_ChIP-Seq_MEL86_Mouse | 1.00805124 |
116 | CDX2_21074721_ChIP-Seq_CACO-2_Mouse | 1.00201005 |
117 | WT1_20215353_ChIP-ChIP_NEPHRON_PROGENITOR_Mouse | 0.98868602 |
118 | RING1B_27294783_Chip-Seq_ESCs_Mouse | 0.98745766 |
119 | RNF2_18974828_ChIP-Seq_MESCs_Mouse | 0.98361227 |
120 | EZH2_18974828_ChIP-Seq_MESCs_Mouse | 0.98361227 |
121 | NFE2_27457419_Chip-Seq_LIVER_Mouse | 0.97612420 |
122 | TCF21_26020271_ChIP-Seq_SMOOTH_MUSCLE_Human | 0.96209535 |
123 | SMAD4_21741376_ChIP-Seq_HESCs_Human | 0.93149434 |
124 | SMAD2/3_21741376_ChIP-Seq_ESCs_Human | 0.90806816 |
125 | ZIC3_20872845_ChIP-ChIP_MESCs_Mouse | 0.90278355 |
126 | SALL4_18804426_ChIP-ChIP_XEN_Mouse | 0.89915042 |
127 | P63_20808887_ChIP-Seq_KERATINOCYTES_Human | 0.89713113 |
128 | VDR_24787735_ChIP-Seq_THP-1_Human | 0.88688756 |
129 | TFAP2C_20629094_ChIP-Seq_MCF-7_Human | 0.88182458 |
130 | BMI1_19503595_ChIP-Seq_MEFsC_Mouse | 0.86183471 |
131 | GATA2_20887958_ChIP-Seq_HPC-7_Mouse | 0.85861811 |
132 | NANOG_18692474_ChIP-Seq_MEFs_Mouse | 0.85378348 |
133 | CDX2_22108803_ChIP-Seq_LS180_Human | 0.84800993 |
134 | KLF4_26769127_Chip-Seq_PDAC-Cell_line_Human | 0.83269057 |
135 | GATA3_20176728_ChIP-ChIP_TSCs_Mouse | 0.82478882 |
136 | SOX11_22085726_ChIP-Seq_ESNs_Mouse | 0.81321807 |
137 | TAL1_22897851_ChIP-Seq_JUKARTE6-1_Human | 0.80193208 |
138 | GATA2_19941826_ChIP-Seq_K562_Human | 0.80113187 |
139 | CTNNB1_20615089_ChIP-ChIP_FETAL_BRAIN_Human | 0.79510053 |
140 | RAD21_21589869_ChIP-Seq_MESCs_Mouse | 0.78615196 |
141 | TP63_23658742_ChIP-Seq_EP156T_Human | 0.78001378 |
142 | RAC3_21632823_ChIP-Seq_H3396_Human | 0.77794479 |
143 | WT1_25993318_ChIP-Seq_PODOCYTE_Human | 0.76877439 |
144 | MTF2_20144788_ChIP-Seq_MESCs_Mouse | 0.76811032 |
145 | FOXA1_21915096_ChIP-Seq_LNCaP-1F5_Human | 0.76426477 |
146 | MYC_19915707_ChIP-ChIP_AK7_Human | 0.76158085 |
147 | CREB1_26743006_Chip-Seq_LNCaP_Human | 0.75895165 |
148 | SMC4_20622854_ChIP-Seq_HELA_Human | 0.75501632 |
149 | P300_27058665_Chip-Seq_ZR-75-30cells_Human | 0.75346933 |
150 | CREB1_26743006_Chip-Seq_LNCaP-abl_Human | 0.75240367 |
151 | NANOG_18700969_ChIP-ChIP_MESCs_Mouse | 0.73729820 |
152 | NR1H3_23393188_ChIP-Seq_ATHEROSCLEROTIC-FOAM_Human | 0.73598187 |
153 | EWS-FLI1_20517297_ChIP-Seq_SK-N-MC_Human | 0.73583373 |
154 | NFE2L2_20460467_ChIP-Seq_MEFs_Mouse | 0.72632870 |
155 | NRF2_20460467_ChIP-Seq_MEFs_Mouse | 0.72632870 |
156 | AHR_22903824_ChIP-Seq_MCF-7_Human | 0.70961698 |
157 | CJUN_26792858_Chip-Seq_BT549_Human | 0.69725038 |
158 | CSB_26484114_Chip-Seq_FIBROBLAST_Human | 0.69371805 |
159 | GATA1_19941826_ChIP-Seq_K562_Human | 0.68988694 |
160 | ARNT_22903824_ChIP-Seq_MCF-7_Human | 0.68846221 |
Rank | Gene Set | Z-score |
---|---|---|
1 | MP0004043_abnormal_pH_regulation | 7.72937175 |
2 | MP0005360_urolithiasis | 7.48025854 |
3 | MP0003195_calcinosis | 5.60756144 |
4 | MP0004019_abnormal_vitamin_homeostasis | 4.76393552 |
5 | * MP0005332_abnormal_amino_acid | 4.58920046 |
6 | * MP0009643_abnormal_urine_homeostasis | 4.05681252 |
7 | MP0002139_abnormal_hepatobiliary_system | 3.91984046 |
8 | * MP0001765_abnormal_ion_homeostasis | 3.77718899 |
9 | MP0002138_abnormal_hepatobiliary_system | 3.68101495 |
10 | * MP0001756_abnormal_urination | 3.53437975 |
11 | * MP0002136_abnormal_kidney_physiology | 3.10990951 |
12 | * MP0005636_abnormal_mineral_homeostasis | 3.04380157 |
13 | MP0003878_abnormal_ear_physiology | 2.78689381 |
14 | MP0005377_hearing/vestibular/ear_phenot | 2.78689381 |
15 | MP0008875_abnormal_xenobiotic_pharmacok | 2.55495726 |
16 | MP0001958_emphysema | 2.48803707 |
17 | MP0003252_abnormal_bile_duct | 2.45008900 |
18 | MP0005365_abnormal_bile_salt | 2.20475930 |
19 | MP0004885_abnormal_endolymph | 1.94404449 |
20 | MP0000538_abnormal_urinary_bladder | 1.87549574 |
21 | MP0005085_abnormal_gallbladder_physiolo | 1.85912748 |
22 | MP0005058_abnormal_lysosome_morphology | 1.75433094 |
23 | MP0003186_abnormal_redox_activity | 1.59937151 |
24 | MP0005584_abnormal_enzyme/coenzyme_acti | 1.57283858 |
25 | MP0003300_gastrointestinal_ulcer | 1.47462072 |
26 | MP0000230_abnormal_systemic_arterial | 1.44863998 |
27 | MP0002168_other_aberrant_phenotype | 1.44834473 |
28 | MP0005451_abnormal_body_composition | 1.37496500 |
29 | MP0002928_abnormal_bile_duct | 1.28355523 |
30 | MP0005319_abnormal_enzyme/_coenzyme | 1.26296852 |
31 | MP0002876_abnormal_thyroid_physiology | 1.24550021 |
32 | MP0006036_abnormal_mitochondrial_physio | 1.22550092 |
33 | MP0003045_fibrosis | 1.22514439 |
34 | MP0003283_abnormal_digestive_organ | 1.21896594 |
35 | * MP0002135_abnormal_kidney_morphology | 1.18222531 |
36 | MP0005084_abnormal_gallbladder_morpholo | 1.15159554 |
37 | MP0003806_abnormal_nucleotide_metabolis | 1.11933066 |
38 | MP0003191_abnormal_cellular_cholesterol | 1.02312078 |
39 | MP0010234_abnormal_vibrissa_follicle | 0.98082860 |
40 | MP0001764_abnormal_homeostasis | 0.96268509 |
41 | MP0005670_abnormal_white_adipose | 0.95446550 |
42 | MP0002896_abnormal_bone_mineralization | 0.93686246 |
43 | MP0005666_abnormal_adipose_tissue | 0.91401869 |
44 | MP0009672_abnormal_birth_weight | 0.91280343 |
45 | MP0001666_abnormal_nutrient_absorption | 0.90035923 |
46 | MP0004147_increased_porphyrin_level | 0.85599640 |
47 | MP0003638_abnormal_response/metabolism_ | 0.85057045 |
48 | MP0004264_abnormal_extraembryonic_tissu | 0.82409501 |
49 | MP0001661_extended_life_span | 0.82154723 |
50 | MP0003646_muscle_fatigue | 0.79686577 |
51 | MP0005395_other_phenotype | 0.76820683 |
52 | * MP0005535_abnormal_body_temperature | 0.76684512 |
53 | MP0002089_abnormal_postnatal_growth/wei | 0.74829407 |
54 | * MP0002118_abnormal_lipid_homeostasis | 0.71902236 |
55 | * MP0009642_abnormal_blood_homeostasis | 0.71782599 |
56 | MP0005220_abnormal_exocrine_pancreas | 0.69694056 |
57 | MP0003183_abnormal_peptide_metabolism | 0.69607276 |
58 | MP0001191_abnormal_skin_condition | 0.67110578 |
59 | MP0000534_abnormal_ureter_morphology | 0.65722086 |
60 | MP0010386_abnormal_urinary_bladder | 0.63874371 |
61 | MP0004272_abnormal_basement_membrane | 0.61703969 |
62 | MP0002796_impaired_skin_barrier | 0.60735935 |
63 | MP0009764_decreased_sensitivity_to | 0.59795187 |
64 | MP0000747_muscle_weakness | 0.59683015 |
65 | MP0003943_abnormal_hepatobiliary_system | 0.59043365 |
66 | MP0010329_abnormal_lipoprotein_level | 0.58207166 |
67 | MP0003172_abnormal_lysosome_physiology | 0.58022490 |
68 | MP0005165_increased_susceptibility_to | 0.57288533 |
69 | MP0000609_abnormal_liver_physiology | 0.55026385 |
70 | MP0004742_abnormal_vestibular_system | 0.53550632 |
71 | MP0003938_abnormal_ear_development | 0.52598201 |
72 | MP0008469_abnormal_protein_level | 0.50249528 |
73 | MP0002971_abnormal_brown_adipose | 0.49847859 |
74 | MP0003329_amyloid_beta_deposits | 0.48963083 |
75 | MP0002069_abnormal_eating/drinking_beha | 0.48657226 |
76 | MP0003315_abnormal_perineum_morphology | 0.47835311 |
77 | MP0001485_abnormal_pinna_reflex | 0.47707977 |
78 | MP0004484_altered_response_of | 0.45635232 |
79 | MP0001270_distended_abdomen | 0.45219418 |
80 | MP0002078_abnormal_glucose_homeostasis | 0.45055269 |
81 | MP0000371_diluted_coat_color | 0.44555043 |
82 | MP0000598_abnormal_liver_morphology | 0.43776040 |
83 | MP0002998_abnormal_bone_remodeling | 0.42997443 |
84 | MP0005167_abnormal_blood-brain_barrier | 0.42710123 |
85 | MP0005501_abnormal_skin_physiology | 0.42166276 |
86 | MP0003953_abnormal_hormone_level | 0.41806967 |
87 | MP0002115_abnormal_skeleton_extremities | 0.41661119 |
88 | MP0003879_abnormal_hair_cell | 0.41053726 |
89 | MP0006035_abnormal_mitochondrial_morpho | 0.40703044 |
90 | MP0009703_decreased_birth_body | 0.40290498 |
91 | MP0001731_abnormal_postnatal_growth | 0.39945207 |
92 | MP0005375_adipose_tissue_phenotype | 0.38857205 |
93 | MP0005408_hypopigmentation | 0.37842942 |
94 | MP0003221_abnormal_cardiomyocyte_apopto | 0.37302390 |
95 | MP0001944_abnormal_pancreas_morphology | 0.36563192 |
96 | MP0004233_abnormal_muscle_weight | 0.36511319 |
97 | MP0004858_abnormal_nervous_system | 0.35817695 |
98 | MP0002098_abnormal_vibrissa_morphology | 0.35440182 |
99 | * MP0003795_abnormal_bone_structure | 0.35125290 |
100 | MP0000026_abnormal_inner_ear | 0.34836491 |
101 | MP0003941_abnormal_skin_development | 0.34636018 |
102 | MP0008004_abnormal_stomach_pH | 0.32871212 |
103 | MP0008872_abnormal_physiological_respon | 0.31819441 |
104 | MP0001963_abnormal_hearing_physiology | 0.31597477 |
105 | MP0000678_abnormal_parathyroid_gland | 0.31344716 |
106 | MP0003075_altered_response_to | 0.30439587 |
107 | MP0002972_abnormal_cardiac_muscle | 0.30332779 |
108 | MP0001663_abnormal_digestive_system | 0.29619080 |
109 | MP0008775_abnormal_heart_ventricle | 0.29418687 |
110 | MP0001177_atelectasis | 0.29245929 |
111 | MP0000163_abnormal_cartilage_morphology | 0.29208942 |
112 | MP0000631_abnormal_neuroendocrine_gland | 0.28849898 |
113 | MP0001727_abnormal_embryo_implantation | 0.28563933 |
114 | MP0010368_abnormal_lymphatic_system | 0.28033547 |
115 | MP0001664_abnormal_digestion | 0.27799570 |
116 | MP0002108_abnormal_muscle_morphology | 0.26791168 |
117 | MP0004215_abnormal_myocardial_fiber | 0.24985481 |
118 | MP0001784_abnormal_fluid_regulation | 0.23441821 |
119 | MP0010770_preweaning_lethality | 0.22920844 |
120 | MP0002082_postnatal_lethality | 0.22920844 |
121 | MP0000566_synostosis | 0.21813151 |
122 | MP0010769_abnormal_survival | 0.18119925 |
123 | MP0008874_decreased_physiological_sensi | 0.17931130 |
124 | MP0010768_mortality/aging | 0.16135093 |
125 | MP0003137_abnormal_impulse_conducting | 0.15728076 |
126 | MP0000681_abnormal_thyroid_gland | 0.15230783 |
127 | MP0003011_delayed_dark_adaptation | 0.15112926 |
128 | MP0000013_abnormal_adipose_tissue | 0.12937391 |
129 | MP0000762_abnormal_tongue_morphology | 0.12005916 |
130 | MP0005409_darkened_coat_color | 0.11361214 |
131 | MP0009780_abnormal_chondrocyte_physiolo | 0.10768928 |
132 | MP0003942_abnormal_urinary_system | 0.10519168 |
133 | MP0000467_abnormal_esophagus_morphology | 0.06997015 |
134 | MP0000367_abnormal_coat/_hair | 0.06367132 |
135 | MP0002113_abnormal_skeleton_development | 0.05425298 |
136 | MP0001346_abnormal_lacrimal_gland | 0.05415261 |
Rank | Gene Set | Z-score |
---|---|---|
1 | Increased circulating renin level (HP:0000848) | 9.28040558 |
2 | Hypokalemic alkalosis (HP:0001949) | 9.00102691 |
3 | Metabolic alkalosis (HP:0200114) | 8.89043156 |
4 | Hypomagnesemia (HP:0002917) | 8.23295120 |
5 | Hyperactive renin-angiotensin system (HP:0000841) | 7.93577162 |
6 | Polyuria (HP:0000103) | 7.70193817 |
7 | Abnormality of chloride homeostasis (HP:0011422) | 7.42825309 |
8 | Abnormal urine output (HP:0012590) | 7.20913517 |
9 | Abnormality of magnesium homeostasis (HP:0004921) | 6.98797647 |
10 | Abnormality of renal excretion (HP:0011036) | 6.62837898 |
11 | Polydipsia (HP:0001959) | 6.21582142 |
12 | Abnormal drinking behavior (HP:0030082) | 6.21582142 |
13 | Tetany (HP:0001281) | 6.12106850 |
14 | Renal salt wasting (HP:0000127) | 5.87205025 |
15 | Hyperaldosteronism (HP:0000859) | 5.78211347 |
16 | Abnormality of renin-angiotensin system (HP:0000847) | 5.60382424 |
17 | Alkalosis (HP:0001948) | 5.57511339 |
18 | Proximal tubulopathy (HP:0000114) | 4.66670012 |
19 | Hypokalemia (HP:0002900) | 4.44881476 |
20 | Hyperglycinuria (HP:0003108) | 4.26532399 |
21 | Abnormality of glutamine family amino acid metabolism (HP:0010902) | 4.17851296 |
22 | Hypercalciuria (HP:0002150) | 4.10137172 |
23 | * Gout (HP:0001997) | 3.80674684 |
24 | Abnormality of potassium homeostasis (HP:0011042) | 3.67591981 |
25 | Abnormality of glycine metabolism (HP:0010895) | 3.50442343 |
26 | Abnormality of serine family amino acid metabolism (HP:0010894) | 3.50442343 |
27 | Ketoacidosis (HP:0001993) | 3.47852329 |
28 | * Hyperuricemia (HP:0002149) | 3.46060931 |
29 | * Increased purine levels (HP:0004368) | 3.46060931 |
30 | Renal tubular acidosis (HP:0001947) | 3.39718531 |
31 | Large eyes (HP:0001090) | 3.36082544 |
32 | Generalized aminoaciduria (HP:0002909) | 3.29155307 |
33 | Abnormality of fatty-acid metabolism (HP:0004359) | 3.14809361 |
34 | * Abnormality of purine metabolism (HP:0004352) | 3.13276198 |
35 | Nephrocalcinosis (HP:0000121) | 3.00788412 |
36 | Abnormality of urine glucose concentration (HP:0011016) | 3.00114965 |
37 | Glycosuria (HP:0003076) | 3.00114965 |
38 | Abnormality of sodium homeostasis (HP:0010931) | 2.98478298 |
39 | Ketosis (HP:0001946) | 2.91196202 |
40 | Hyponatremia (HP:0002902) | 2.78511005 |
41 | Adrenal overactivity (HP:0002717) | 2.71919449 |
42 | Hyperphosphaturia (HP:0003109) | 2.68615938 |
43 | Dehydration (HP:0001944) | 2.64851540 |
44 | Abnormality of proline metabolism (HP:0010907) | 2.62900274 |
45 | Hydroxyprolinuria (HP:0003080) | 2.62900274 |
46 | Abnormal urine phosphate concentration (HP:0012599) | 2.55276807 |
47 | Delayed epiphyseal ossification (HP:0002663) | 2.51844063 |
48 | Abnormality of aspartate family amino acid metabolism (HP:0010899) | 2.47554367 |
49 | Chondrocalcinosis (HP:0000934) | 2.47117969 |
50 | Nephrolithiasis (HP:0000787) | 2.46972084 |
51 | Hyperglycinemia (HP:0002154) | 2.40653681 |
52 | Delayed CNS myelination (HP:0002188) | 2.36853636 |
53 | Abnormality of Sharpey fibers (HP:0100685) | 2.32597732 |
54 | * Abnormality of nucleobase metabolism (HP:0010932) | 2.26164058 |
55 | Hypophosphatemia (HP:0002148) | 2.22878639 |
56 | Vomiting (HP:0002013) | 2.21311988 |
57 | Vascular calcification (HP:0004934) | 2.16640543 |
58 | Metaphyseal cupping (HP:0003021) | 2.13137423 |
59 | Tubulointerstitial fibrosis (HP:0005576) | 2.11914267 |
60 | Potter facies (HP:0002009) | 2.11646790 |
61 | Facial shape deformation (HP:0011334) | 2.11646790 |
62 | Hyperammonemia (HP:0001987) | 2.11370160 |
63 | Rickets (HP:0002748) | 2.06989292 |
64 | Renal tubular dysfunction (HP:0000124) | 2.05240881 |
65 | Generalized muscle weakness (HP:0003324) | 2.05202057 |
66 | Metabolic acidosis (HP:0001942) | 2.04204113 |
67 | Dicarboxylic aciduria (HP:0003215) | 2.03573452 |
68 | Abnormality of dicarboxylic acid metabolism (HP:0010995) | 2.03573452 |
69 | Widely patent fontanelles and sutures (HP:0004492) | 2.03531875 |
70 | Decreased circulating renin level (HP:0003351) | 2.00384245 |
71 | Hypotension (HP:0002615) | 1.98903116 |
72 | Vacuolated lymphocytes (HP:0001922) | 1.98437465 |
73 | Enlarged kidneys (HP:0000105) | 1.96674388 |
74 | Abnormality of renal resorption (HP:0011038) | 1.94000947 |
75 | Cardiovascular calcification (HP:0011915) | 1.92927001 |
76 | Abnormality of sulfur amino acid metabolism (HP:0004339) | 1.89975336 |
77 | Glomerulosclerosis (HP:0000096) | 1.84284775 |
78 | Confusion (HP:0001289) | 1.81454653 |
79 | Malnutrition (HP:0004395) | 1.81167900 |
80 | Bilateral sensorineural hearing impairment (HP:0008619) | 1.80757329 |
81 | Lethargy (HP:0001254) | 1.77531652 |
82 | Abnormality of aromatic amino acid family metabolism (HP:0004338) | 1.73651695 |
83 | Thin bony cortex (HP:0002753) | 1.71769336 |
84 | Abnormal platelet function (HP:0011869) | 1.70779532 |
85 | Impaired platelet aggregation (HP:0003540) | 1.70779532 |
86 | Lymphangioma (HP:0100764) | 1.70020578 |
87 | Abnormal enzyme/coenzyme activity (HP:0012379) | 1.69435969 |
88 | Methylmalonic aciduria (HP:0012120) | 1.69073171 |
89 | Neonatal onset (HP:0003623) | 1.66642357 |
90 | Abnormality of alkaline phosphatase activity (HP:0004379) | 1.64260021 |
91 | Abnormal tarsal ossification (HP:0008369) | 1.64087834 |
92 | Bicornuate uterus (HP:0000813) | 1.62586199 |
93 | Hyperkalemia (HP:0002153) | 1.57688143 |
94 | Intracellular accumulation of autofluorescent lipopigment storage material (HP:0003204) | 1.57269926 |
95 | Irritability (HP:0000737) | 1.56864639 |
96 | Nausea (HP:0002018) | 1.53183838 |
97 | Focal segmental glomerulosclerosis (HP:0000097) | 1.51216485 |
98 | Nephrogenic diabetes insipidus (HP:0009806) | 1.48531550 |
99 | Tachypnea (HP:0002789) | 1.46705088 |
100 | Abnormality of the costochondral junction (HP:0000919) | 1.45953691 |
101 | Premature birth (HP:0001622) | 1.45113594 |
102 | Abnormality of serum amino acid levels (HP:0003112) | 1.39995548 |
103 | Abnormal eating behavior (HP:0100738) | 1.39864379 |
104 | Metaphyseal dysplasia (HP:0100255) | 1.39485065 |
105 | Abnormality of the renal cortex (HP:0011035) | 1.38750426 |
106 | Metaphyseal irregularity (HP:0003025) | 1.38180311 |
107 | Osteopenia (HP:0000938) | 1.34774767 |
108 | Paresthesia (HP:0003401) | 1.30068433 |
109 | Hypothermia (HP:0002045) | 1.26427330 |
110 | Intellectual disability, moderate (HP:0002342) | 1.10250896 |
111 | Tubulointerstitial abnormality (HP:0001969) | 1.10214177 |
112 | Elevated alkaline phosphatase (HP:0003155) | 1.09837198 |
113 | Abnormality of calcium-phosphate metabolism (HP:0100530) | 1.06568161 |
114 | Polyhydramnios (HP:0001561) | 1.05697566 |
115 | Small for gestational age (HP:0001518) | 1.05194016 |
116 | Neonatal death (HP:0003811) | 1.03373084 |
117 | Thyroid-stimulating hormone excess (HP:0002925) | 0.93129419 |
118 | Persistence of primary teeth (HP:0006335) | 0.87919698 |
119 | Osteomalacia (HP:0002749) | 0.78278602 |
120 | Hyperphosphatemia (HP:0002905) | 0.76166764 |
121 | Hypophosphatemic rickets (HP:0004912) | 0.76161187 |
122 | Abnormality of the fingertips (HP:0001211) | 0.75411803 |
123 | Enlarged epiphyses (HP:0010580) | 0.74971753 |
124 | Abnormality of macular pigmentation (HP:0008002) | 0.74622086 |
125 | Esophageal varix (HP:0002040) | 0.71524291 |
126 | Abnormal foot bone ossification (HP:0010675) | 0.64655885 |
127 | Amelogenesis imperfecta (HP:0000705) | 0.64263794 |
128 | Pancreatic cysts (HP:0001737) | 0.63614644 |
129 | Stage 5 chronic kidney disease (HP:0003774) | 0.62619337 |
130 | * Tubular atrophy (HP:0000092) | 0.61059041 |
131 | Choanal stenosis (HP:0000452) | 0.58968191 |
132 | Visceral angiomatosis (HP:0100761) | 0.58825131 |
Rank | Gene Set | Z-score |
---|---|---|
1 | WNK3 | 9.24167215 |
2 | WNK4 | 8.85390417 |
3 | OXSR1 | 8.15719158 |
4 | STK39 | 4.68314577 |
5 | BCKDK | 2.15634620 |
6 | STK38L | 1.82174947 |
7 | WNK1 | 1.80143893 |
8 | SGK223 | 1.77274252 |
9 | SGK494 | 1.77274252 |
10 | PDK3 | 1.60262776 |
11 | PDK4 | 1.60262776 |
12 | NEK1 | 1.46859141 |
13 | PDK2 | 1.29273941 |
14 | SGK2 | 1.25424267 |
15 | SGK3 | 1.13255763 |
16 | MST4 | 0.96955660 |
17 | STK38 | 0.93842819 |
18 | TIE1 | 0.88817614 |
19 | MST1R | 0.88308291 |
20 | LRRK2 | 0.79091753 |
21 | TGFBR2 | 0.69531056 |
22 | FGFR4 | 0.63983074 |
23 | EPHB1 | 0.58909968 |
24 | GSK3A | 0.55907842 |
25 | PINK1 | 0.55270492 |
26 | SGK1 | 0.53139497 |
27 | MAP3K7 | 0.49725509 |
28 | ERN1 | 0.45869702 |
29 | GRK6 | 0.45813443 |
30 | PRKAA1 | 0.44031345 |
31 | MAP3K3 | 0.42536810 |
32 | PAK4 | 0.41432618 |
33 | PTK2 | 0.39344899 |
34 | PTK6 | 0.34892218 |
35 | ABL2 | 0.33630388 |
36 | PDPK1 | 0.33363955 |
37 | DYRK1B | 0.32202439 |
38 | TRIB3 | 0.30166324 |
39 | FER | 0.29705662 |
40 | PAK3 | 0.27798859 |
41 | PRKD2 | 0.26693114 |
42 | PRKAA2 | 0.25513337 |
43 | STK10 | 0.25285991 |
44 | MET | 0.24062531 |
45 | MYLK | 0.23936473 |
46 | MAPK11 | 0.23928460 |
47 | RIPK1 | 0.23518489 |
48 | INSRR | 0.23074977 |
49 | PRKCI | 0.22844314 |
50 | PIK3CG | 0.21480178 |
51 | PTK2B | 0.21376675 |
52 | NTRK1 | 0.21049858 |
53 | PDK1 | 0.20636323 |
54 | MAPK15 | 0.19415346 |
55 | PRKCZ | 0.19111397 |
56 | PRKCH | 0.16818127 |
57 | PRKCD | 0.16005105 |
58 | LATS1 | 0.15918185 |
59 | MAP3K2 | 0.15868077 |
60 | KDR | 0.15075901 |
61 | MAP3K14 | 0.13836136 |
62 | PRKACG | 0.13322644 |
63 | FRK | 0.12685316 |
64 | EPHB2 | 0.12190106 |
65 | STK11 | 0.11955625 |
66 | MAP2K3 | 0.11425823 |
67 | TGFBR1 | 0.10713717 |
68 | JAK2 | 0.10015838 |
69 | AKT2 | 0.09936043 |
70 | BMX | 0.09090688 |
71 | SCYL2 | 0.08245064 |
72 | PRKACA | 0.07692328 |
73 | MINK1 | 0.07686197 |
74 | PRKCA | 0.07476205 |
75 | ERBB4 | 0.06955547 |
76 | NME2 | 0.06143731 |
77 | NLK | 0.05659590 |
78 | IRAK2 | 0.05582772 |
79 | ROCK1 | 0.05086455 |
80 | EPHA3 | 0.04969873 |
81 | TESK1 | 0.04269338 |
82 | MAPK12 | 0.04159072 |
83 | CSNK1A1 | 0.03629970 |
84 | PDGFRA | 0.03356544 |
85 | FGFR3 | 0.03338637 |
86 | PRKCB | 0.02969683 |
87 | PIM1 | 0.02518757 |
88 | SRC | 0.02293572 |
89 | AKT3 | 0.02248635 |
90 | MAP3K11 | 0.01517848 |
91 | CSNK1A1L | 0.01346555 |
92 | PRKD3 | 0.01013556 |
93 | KSR2 | 0.00669321 |
94 | BRSK2 | 0.00644352 |
95 | INSR | 0.00439116 |
96 | RET | 0.00236721 |
97 | EPHA4 | 0.00101222 |
98 | BTK | -0.0878783 |
99 | AURKB | -0.0859066 |
100 | PRKACB | -0.0848090 |
101 | MAP3K1 | -0.0837103 |
102 | ADRBK2 | -0.0825285 |
103 | CAMK2B | -0.0818625 |
104 | DMPK | -0.0804106 |
105 | MAPK3 | -0.0794247 |
106 | CSF1R | -0.0782563 |
107 | PRKG1 | -0.0776820 |
108 | FYN | -0.0774843 |
109 | MELK | -0.0719797 |
110 | KSR1 | -0.0712806 |
111 | PIK3CA | -0.0711115 |
112 | LATS2 | -0.0659036 |
113 | MAPK8 | -0.0652262 |
114 | JAK1 | -0.0600718 |
115 | MAPK10 | -0.0595191 |
116 | ROCK2 | -0.0584001 |
117 | PRKCE | -0.0562639 |
118 | NTRK3 | -0.0474100 |
119 | NEK9 | -0.0436258 |
120 | ABL1 | -0.0413680 |
121 | FGFR2 | -0.0411102 |
122 | CDC42BPA | -0.0394405 |
123 | PRKD1 | -0.0385990 |
124 | PKN2 | -0.0382109 |
125 | CAMK4 | -0.0348427 |
126 | BCR | -0.0346915 |
127 | MAP2K4 | -0.0343237 |
128 | DAPK2 | -0.0306469 |
129 | RPS6KA3 | -0.0277332 |
130 | GRK1 | -0.0266935 |
131 | PRKCG | -0.0241960 |
132 | IRAK1 | -0.0236329 |
133 | MARK3 | -0.0223115 |
134 | CSK | -0.0214582 |
135 | PRKCQ | -0.0204254 |
136 | TRPM7 | -0.0171148 |
137 | MTOR | -0.0148884 |
138 | YES1 | -0.0148493 |
139 | CAMKK2 | -0.0067450 |
140 | IGF1R | -0.0061565 |
141 | STK3 | -0.0039282 |
Rank | Gene Set | Z-score |
---|---|---|
1 | Proximal tubule bicarbonate reclamation_Homo sapiens_hsa04964 | 3.76561144 |
2 | Synthesis and degradation of ketone bodies_Homo sapiens_hsa00072 | 3.60724174 |
3 | Butanoate metabolism_Homo sapiens_hsa00650 | 3.53440493 |
4 | 2-Oxocarboxylic acid metabolism_Homo sapiens_hsa01210 | 3.32685636 |
5 | Cyanoamino acid metabolism_Homo sapiens_hsa00460 | 3.29045808 |
6 | Propanoate metabolism_Homo sapiens_hsa00640 | 3.28042108 |
7 | Valine, leucine and isoleucine degradation_Homo sapiens_hsa00280 | 3.27575804 |
8 | Glyoxylate and dicarboxylate metabolism_Homo sapiens_hsa00630 | 3.25312032 |
9 | Ascorbate and aldarate metabolism_Homo sapiens_hsa00053 | 2.89664237 |
10 | Citrate cycle (TCA cycle)_Homo sapiens_hsa00020 | 2.67541459 |
11 | Pentose and glucuronate interconversions_Homo sapiens_hsa00040 | 2.49384477 |
12 | Collecting duct acid secretion_Homo sapiens_hsa04966 | 2.38066996 |
13 | Peroxisome_Homo sapiens_hsa04146 | 2.37574567 |
14 | Fatty acid degradation_Homo sapiens_hsa00071 | 2.35910722 |
15 | Pyruvate metabolism_Homo sapiens_hsa00620 | 2.26694276 |
16 | Tryptophan metabolism_Homo sapiens_hsa00380 | 2.22000806 |
17 | Vitamin digestion and absorption_Homo sapiens_hsa04977 | 2.08481493 |
18 | Phenylalanine, tyrosine and tryptophan biosynthesis_Homo sapiens_hsa00400 | 1.97807777 |
19 | Bile secretion_Homo sapiens_hsa04976 | 1.83942323 |
20 | Glycine, serine and threonine metabolism_Homo sapiens_hsa00260 | 1.82191359 |
21 | beta-Alanine metabolism_Homo sapiens_hsa00410 | 1.81317782 |
22 | Carbon metabolism_Homo sapiens_hsa01200 | 1.75730788 |
23 | Taurine and hypotaurine metabolism_Homo sapiens_hsa00430 | 1.75039032 |
24 | Fatty acid metabolism_Homo sapiens_hsa01212 | 1.73328444 |
25 | Endocrine and other factor-regulated calcium reabsorption_Homo sapiens_hsa04961 | 1.71589683 |
26 | Sulfur metabolism_Homo sapiens_hsa00920 | 1.67271176 |
27 | Aldosterone-regulated sodium reabsorption_Homo sapiens_hsa04960 | 1.60887603 |
28 | Glutathione metabolism_Homo sapiens_hsa00480 | 1.60229349 |
29 | Endometrial cancer_Homo sapiens_hsa05213 | 1.56722192 |
30 | Biosynthesis of unsaturated fatty acids_Homo sapiens_hsa01040 | 1.40763311 |
31 | Protein digestion and absorption_Homo sapiens_hsa04974 | 1.40292087 |
32 | Non-small cell lung cancer_Homo sapiens_hsa05223 | 1.38682148 |
33 | Mineral absorption_Homo sapiens_hsa04978 | 1.35848614 |
34 | Lysine degradation_Homo sapiens_hsa00310 | 1.35670290 |
35 | Arginine biosynthesis_Homo sapiens_hsa00220 | 1.27211697 |
36 | Pancreatic cancer_Homo sapiens_hsa05212 | 1.26602467 |
37 | PPAR signaling pathway_Homo sapiens_hsa03320 | 1.26456672 |
38 | Arginine and proline metabolism_Homo sapiens_hsa00330 | 1.25041750 |
39 | Nitrogen metabolism_Homo sapiens_hsa00910 | 1.22761774 |
40 | Other glycan degradation_Homo sapiens_hsa00511 | 1.21233131 |
41 | Glycolysis / Gluconeogenesis_Homo sapiens_hsa00010 | 1.12852940 |
42 | Biosynthesis of amino acids_Homo sapiens_hsa01230 | 1.12226494 |
43 | Glioma_Homo sapiens_hsa05214 | 1.08805026 |
44 | Melanoma_Homo sapiens_hsa05218 | 1.07703865 |
45 | Mucin type O-Glycan biosynthesis_Homo sapiens_hsa00512 | 1.05313993 |
46 | Pantothenate and CoA biosynthesis_Homo sapiens_hsa00770 | 1.00946539 |
47 | Selenocompound metabolism_Homo sapiens_hsa00450 | 0.99259832 |
48 | Alanine, aspartate and glutamate metabolism_Homo sapiens_hsa00250 | 0.93486596 |
49 | Primary bile acid biosynthesis_Homo sapiens_hsa00120 | 0.92980753 |
50 | Renin-angiotensin system_Homo sapiens_hsa04614 | 0.90911730 |
51 | Starch and sucrose metabolism_Homo sapiens_hsa00500 | 0.89853046 |
52 | Oxidative phosphorylation_Homo sapiens_hsa00190 | 0.88881574 |
53 | FoxO signaling pathway_Homo sapiens_hsa04068 | 0.83417584 |
54 | Phenylalanine metabolism_Homo sapiens_hsa00360 | 0.82850149 |
55 | Drug metabolism - cytochrome P450_Homo sapiens_hsa00982 | 0.82526219 |
56 | Folate biosynthesis_Homo sapiens_hsa00790 | 0.81307368 |
57 | Fructose and mannose metabolism_Homo sapiens_hsa00051 | 0.81138421 |
58 | Glycerolipid metabolism_Homo sapiens_hsa00561 | 0.80656348 |
59 | Vitamin B6 metabolism_Homo sapiens_hsa00750 | 0.80329288 |
60 | Cysteine and methionine metabolism_Homo sapiens_hsa00270 | 0.77144616 |
61 | Histidine metabolism_Homo sapiens_hsa00340 | 0.77089729 |
62 | Carbohydrate digestion and absorption_Homo sapiens_hsa04973 | 0.73808040 |
63 | Fatty acid elongation_Homo sapiens_hsa00062 | 0.71917929 |
64 | Gap junction_Homo sapiens_hsa04540 | 0.70700224 |
65 | Prostate cancer_Homo sapiens_hsa05215 | 0.70031663 |
66 | ErbB signaling pathway_Homo sapiens_hsa04012 | 0.68363457 |
67 | Lysosome_Homo sapiens_hsa04142 | 0.64198812 |
68 | Gastric acid secretion_Homo sapiens_hsa04971 | 0.63688643 |
69 | Thyroid hormone synthesis_Homo sapiens_hsa04918 | 0.62352173 |
70 | Pentose phosphate pathway_Homo sapiens_hsa00030 | 0.56569957 |
71 | Chemical carcinogenesis_Homo sapiens_hsa05204 | 0.54471320 |
72 | Regulation of lipolysis in adipocytes_Homo sapiens_hsa04923 | 0.54438376 |
73 | HIF-1 signaling pathway_Homo sapiens_hsa04066 | 0.52736037 |
74 | Parkinsons disease_Homo sapiens_hsa05012 | 0.51032400 |
75 | Metabolism of xenobiotics by cytochrome P450_Homo sapiens_hsa00980 | 0.50228775 |
76 | Thyroid cancer_Homo sapiens_hsa05216 | 0.50222656 |
77 | Metabolic pathways_Homo sapiens_hsa01100 | 0.49796975 |
78 | Vasopressin-regulated water reabsorption_Homo sapiens_hsa04962 | 0.45200383 |
79 | Steroid hormone biosynthesis_Homo sapiens_hsa00140 | 0.44025217 |
80 | Maturity onset diabetes of the young_Homo sapiens_hsa04950 | 0.39789776 |
81 | Focal adhesion_Homo sapiens_hsa04510 | 0.39769104 |
82 | Glycosaminoglycan degradation_Homo sapiens_hsa00531 | 0.39423775 |
83 | Vibrio cholerae infection_Homo sapiens_hsa05110 | 0.38001578 |
84 | Complement and coagulation cascades_Homo sapiens_hsa04610 | 0.36064286 |
85 | Drug metabolism - other enzymes_Homo sapiens_hsa00983 | 0.34050881 |
86 | Regulation of actin cytoskeleton_Homo sapiens_hsa04810 | 0.33062553 |
87 | Phospholipase D signaling pathway_Homo sapiens_hsa04072 | 0.28961934 |
88 | Synaptic vesicle cycle_Homo sapiens_hsa04721 | 0.27745295 |
89 | Epithelial cell signaling in Helicobacter pylori infection_Homo sapiens_hsa05120 | 0.27721869 |
90 | Cardiac muscle contraction_Homo sapiens_hsa04260 | 0.26819160 |
91 | Retinol metabolism_Homo sapiens_hsa00830 | 0.26622698 |
92 | Terpenoid backbone biosynthesis_Homo sapiens_hsa00900 | 0.24910101 |
93 | Glycosphingolipid biosynthesis - globo series_Homo sapiens_hsa00603 | 0.24709533 |
94 | ABC transporters_Homo sapiens_hsa02010 | 0.24597273 |
95 | Non-alcoholic fatty liver disease (NAFLD)_Homo sapiens_hsa04932 | 0.21818261 |
96 | Rap1 signaling pathway_Homo sapiens_hsa04015 | 0.21781329 |
97 | Alzheimers disease_Homo sapiens_hsa05010 | 0.21288781 |
98 | Tyrosine metabolism_Homo sapiens_hsa00350 | 0.20851756 |
99 | Choline metabolism in cancer_Homo sapiens_hsa05231 | 0.18951489 |
100 | Circadian rhythm_Homo sapiens_hsa04710 | 0.18822667 |
101 | Sulfur relay system_Homo sapiens_hsa04122 | 0.17748436 |
102 | Arachidonic acid metabolism_Homo sapiens_hsa00590 | 0.17287742 |
103 | Steroid biosynthesis_Homo sapiens_hsa00100 | 0.17035676 |
104 | Nicotinate and nicotinamide metabolism_Homo sapiens_hsa00760 | 0.16922088 |
105 | Tight junction_Homo sapiens_hsa04530 | 0.14085439 |
106 | Longevity regulating pathway - mammal_Homo sapiens_hsa04211 | 0.13719052 |
107 | Pathways in cancer_Homo sapiens_hsa05200 | 0.12823544 |
108 | Insulin resistance_Homo sapiens_hsa04931 | 0.11230398 |
109 | Adipocytokine signaling pathway_Homo sapiens_hsa04920 | 0.10978192 |
110 | PI3K-Akt signaling pathway_Homo sapiens_hsa04151 | 0.09989385 |
111 | Sphingolipid metabolism_Homo sapiens_hsa00600 | 0.08746945 |
112 | Bladder cancer_Homo sapiens_hsa05219 | 0.08427477 |
113 | Rheumatoid arthritis_Homo sapiens_hsa05323 | 0.08374637 |
114 | Huntingtons disease_Homo sapiens_hsa05016 | 0.05991926 |
115 | Inositol phosphate metabolism_Homo sapiens_hsa00562 | 0.04865374 |
116 | Leukocyte transendothelial migration_Homo sapiens_hsa04670 | 0.03797523 |
117 | Endocytosis_Homo sapiens_hsa04144 | 0.03287741 |
118 | Pancreatic secretion_Homo sapiens_hsa04972 | 0.02698328 |
119 | Ras signaling pathway_Homo sapiens_hsa04014 | 0.02215103 |
120 | Galactose metabolism_Homo sapiens_hsa00052 | 0.02017249 |
121 | Hepatitis C_Homo sapiens_hsa05160 | 0.01837931 |
122 | AMPK signaling pathway_Homo sapiens_hsa04152 | 0.00639162 |
123 | Glucagon signaling pathway_Homo sapiens_hsa04922 | -0.0324919 |
124 | ECM-receptor interaction_Homo sapiens_hsa04512 | -0.0249193 |
125 | Glycosphingolipid biosynthesis - ganglio series_Homo sapiens_hsa00604 | -0.0188621 |
126 | Porphyrin and chlorophyll metabolism_Homo sapiens_hsa00860 | -0.0098464 |